Beta-L-(-)-dioxolane Cytidine (β-L-(-)-OddC) as a Potent Compound for the Treatment of Cancer

REFERENCES

• Bridges , E. G. and Cheng , Y-C. 1995 . Use of novel beta-L-nucleoside analogues for treatment and prevention of chronic hepatitis B virus infection and hepatocellular carcinoma . Advances in Liver Disease , 13 : 231 – 245 .
   PubMedGoogle Scholar
• Chu , C. K. , Ma , T. , Shanmuganathan , K. , Wang , C. , Xiang , Y. , Pai , S. B. , Yao , G. Q. , Sommadossi , J-P. and Cheng , Y-C. 1995 . 2′-Fluoro-5-methyl-B-L-arabinofuranosyluridine (L-FMAU) as a novel antiviral agent for hepatitis B and Epstein-Barr virus . Antimicrob Agents Chemother , 39 : 979 – 981 .
   PubMed Web of Science ®Google Scholar
• Lin , T-S. , Luo , M. Z. , Liu , M. C. , Pai , S. B. , Dutschman , G. E. and Cheng , Y-C. 1993 . Antiviral activity of 2′,3′-dideoxy-beta-L-5-fluorocytidine and 2′,3′-dideoxy-beta-L-cytidine against hepatitis B virus and human immunodeficiency virus type 1 in vitro . Biochem. Pharm , 47 : 171 – 174 .
   Google Scholar
• Chang , C. N. , Doong , S. L. , Zhou , J. H. , Beach , J. W. , Jeong , L. S. , Chu , C. H. , Tsai , C. K. and Cheng , Y-C. 1992 . Deoxycytidine deaminase resistant stereoisomer is the active form of (+)-2′,3′-dideoxy-3′-thiacytidine in the inhibition of hepatitis B virus replication . J. Biol. Chem. , 267 : 13939 – 13942 .
   Google Scholar
• Schinazi , R. F. , Chu , C. K. , Peck , A. , McMillan , A. , Mathis , R. , Cannon , D. , Jeong , L. S. , Beach , J. W. , Choi , W. B. , Yeola , S. and Liotta , D. C. 1992 . Activities of the four optical isomers of 2′,3′-dideoxy-3′-thiacytidine (BCH-189) against human immunodeficiency virus type 1 in human lymphocytes . Antimicrob. Agents Chemother. , 36 : 672 – 676 .
   PubMed Web of Science ®Google Scholar
• Kim , H. O. , Shanmuganathan , K. , Alves , A. J. , Jeong , L. S. , Beach , J. W. , Schinazi , C. N. , Chang , R. F. , Cheng , Y-C. and Chu , C. K. 1992 . Potent anti-HIV and anti-HBV activities of (-)-beta-L-dioxolane-C and (+)-D-beta-dioxolane T and their asymmetric syntheses . Tet. Lett. , 33 : 6899 – 6902 .
   Web of Science ®Google Scholar
• Grove , K. L. and Cheng , Y-C. 1996 . Uptake and metabolism of the new anticancer compound beta-L-(-)-dioxolane cytidine in human prostate carcinoma DU-145 cells . Cancer Res. , 56 : 4187 – 4191 .
   PubMed Web of Science ®Google Scholar
• Grove , K. L. , Guo , X. , Liu , S-H. , Gao , Z. , Chu , C. K. and Cheng , Y-C. 1995 . Anticancer activity of beta-L-(-)-dioxolane cytidine, a novel nucleoside analogue with the unnatural L configuration . Cancer Res. , 55 : 3008 – 3011 .
   PubMed Web of Science ®Google Scholar
• Heinemann , V. , Xu , Y-Z. , Chubb , S. , Sen , A. , Hertel , L. W. , Grindey , G. B. and Plunkett , W. 1990 . Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2′,2′-difluorodeoxycytidine . Mol. Pharmacol. , 38 : 567 – 572 .
   PubMed Web of Science ®Google Scholar
• Kukhanova , M. , Liu , S-H. , Mozzherin , D. , Lin , T-S. , Chu , C. K. and Cheng , Y-C. 1995 . L- and D-enantiomers of 2′,3′-dideoxycytidine 5′-triphosphate analogs as substrates for human DNA polymerases . J. Biol. Chem. , 39 : 23055 – 23059 .
   Google Scholar
• Gao , W. Y. , Johns , D. G. and Mitsoya , H. Enzymatic assay for the quantification of deoxynucleoside triphosphates in human cells exposed to antiretroviral 2′,3′-dideoxy nucleosides . Analyt. Biochem. , 222 116 – 122 .
   PubMedGoogle Scholar